- Home
- LXRX vs ZTEK Comparison
LXRX vs ZTEK Comparison
Compare LXRX & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- ZTEK
- Stock Information
- Founded
- LXRX 1995
- ZTEK 2008
- Country
- LXRX United States
- ZTEK Canada
- Employees
- LXRX N/A
- ZTEK N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- ZTEK Major Chemicals
- Sector
- LXRX Health Care
- ZTEK Industrials
- Exchange
- LXRX Nasdaq
- ZTEK Nasdaq
- Market Cap
- LXRX 124.4M
- ZTEK 103.3M
- IPO Year
- LXRX 2000
- ZTEK N/A
- Fundamental
- Price
- LXRX $0.70
- ZTEK $1.60
- Analyst Decision
- LXRX Buy
- ZTEK
- Analyst Count
- LXRX 4
- ZTEK 0
- Target Price
- LXRX $3.67
- ZTEK N/A
- AVG Volume (30 Days)
- LXRX 5.7M
- ZTEK 82.9K
- Earning Date
- LXRX 05-13-2025
- ZTEK 06-26-2025
- Dividend Yield
- LXRX N/A
- ZTEK N/A
- EPS Growth
- LXRX N/A
- ZTEK N/A
- EPS
- LXRX N/A
- ZTEK N/A
- Revenue
- LXRX $31,081,000.00
- ZTEK $44,936.00
- Revenue This Year
- LXRX N/A
- ZTEK N/A
- Revenue Next Year
- LXRX $84.78
- ZTEK N/A
- P/E Ratio
- LXRX N/A
- ZTEK N/A
- Revenue Growth
- LXRX 2481.48
- ZTEK 92.38
- 52 Week Low
- LXRX $0.28
- ZTEK $0.50
- 52 Week High
- LXRX $2.45
- ZTEK $1.31
- Technical
- Relative Strength Index (RSI)
- LXRX 60.07
- ZTEK 60.34
- Support Level
- LXRX $0.63
- ZTEK $1.51
- Resistance Level
- LXRX $0.71
- ZTEK $1.83
- Average True Range (ATR)
- LXRX 0.07
- ZTEK 0.18
- MACD
- LXRX -0.00
- ZTEK 0.01
- Stochastic Oscillator
- LXRX 55.00
- ZTEK 68.99
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.